Oxycodone on Packaging Line Leads to Recall of Betaxolol
Betaxolol may cause a slowing in the heart rate in some patients; an opioid could increase the effect.
KVK-Tech is voluntarily recalling one lot of Betaxolol Tablets, USP 10 mg, which is a beta blocker used to treat patients with hypertension and also used to treat glaucoma. The company is making the recall as a precautionary measure after one tablet Oxycodone HCl tablet 5 mg was found on the packaging line of Betaxolol.
KVK has not received any reports of foreign tablet in any bottle of Betaxolol.
Betaxolol has a warning on its label about the possibility of a slowing in the heart rate in elderly patients. This effect could be increased by inadvertent opioid administration. Additionally, some patients prescribed low-dose betaxolol might be have compromised heart and lung function that is also likely to be exacerbated by an opioid, the company said.
The affected Betaxolol has a lot number of 17853A and has an expiration date of June 2027. The batch was distributed nationwide to wholesalers and retailers.
FDA Approves Two More Denosumab Biosimilars, Conexxence and Bomyntra
March 27th 2025The fourth pair of denosumab biosimilars, Conexxence and Bomyntra, are expected to launch in the United States in mid 2025, as a result of a global settlement with Amgen, according to a company news release.
Read More
FDA Approves First Drug for Excess Hunger in Prader-Willi Syndrome
March 27th 2025Vykat XR will be available in April to treat the intense hunger that is a hallmark of the rare genetic disease Prader-Willi syndrome. The price is based on a patient’s weight, and the average patient in the clinical trials would have had an average annual cost of $466,200 for the first year.
Read More
FDA Approves Amvuttra for ATTR-CM in Extended Label
March 21st 2025This expanded indication for Amvuttra makes it the first and only FDA-approved treatment for transthyretin amyloidosis with cardiomyopathy (ATTR-CM) and the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults.
Read More
